Start for free
Start for free
Sio Capital Management logo

Sio Capital Management

North America, New York, United States, New York

Description

Sio Capital Management LLC is an investment management firm .

Investor Profile

Sio Capital Management has made 4 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Life Science
  • Clinical Trials
  • Oncology
  • Therapeutics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sio Capital Management frequently co-invest with?

Altium Capital
Altium Capital
North America, New York, United States, New York
Co-Investments: 2
6C
683 CAPITAL
North America, New York, United States, New York
Co-Investments: 1
RTW Investments
RTW Investments
North America, New York, United States, New York
Co-Investments: 1
Innogest Capital
Innogest Capital
Europe, Lombardia, Italy, Milan
Co-Investments: 1
Ikarian Capital
Ikarian Capital
North America, Texas, United States, Dallas
Co-Investments: 2
Affinity Asset Advisors
Affinity Asset Advisors
North America, New York, United States, New York
Co-Investments: 1
Acorn Bioventures
Acorn Bioventures
North America, New York, United States, New York
Co-Investments: 1
C
Chardan
North America, New York, United States, New York
Co-Investments: 1
LV
Longview Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1
Lincoln Park Capital Fund
Lincoln Park Capital Fund
North America, Illinois, United States, Chicago
Co-Investments: 2

What are some of recent deals done by Sio Capital Management?

Renovacor

Philadelphia, Pennsylvania, United States

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

BiotechnologyHealth CareLife Science
Post Ipo EquitySep 3, 2021
Amount Raised: $30,000,000
X4 Pharmaceuticals

Cambridge, Massachusetts, United States

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

BiotechnologyClinical TrialsHealth CareOncologyPharmaceuticalTherapeutics
Post Ipo EquityMar 19, 2021
Amount Raised: $55,000,000
Ayala Pharmaceuticals

Wilmington, Delaware, United States

Ayala Pharmaceuticals a clinical-stage biopharmaceutical company focused on developing and commercializing small molecule therapeutics.

BiotechnologyPharmaceutical
Post Ipo EquityFeb 19, 2021
Amount Raised: $25,000,000
Onconova Therapeutics

Newtown, Pennsylvania, United States

Onconova Therapeutics is a biopharmaceutical company developing small molecule drug candidates for the treatment of cancer.

BiopharmaBiotechnologyHealth Care
Post Ipo EquityJan 7, 2021
Amount Raised: $8,700,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator